惡性高血壓與肺出血_第1頁
惡性高血壓與肺出血_第2頁
惡性高血壓與肺出血_第3頁
惡性高血壓與肺出血_第4頁
惡性高血壓與肺出血_第5頁
已閱讀5頁,還剩20頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)

文檔簡介

惡性高血壓與肺出血第1頁/共25頁2IgA腎病與肺出血第2頁/共25頁3Pulmonarycapillaritisandalveolarhemorrhage.Updateondiagnosisandmanagement.

Pulmonaryvascularinflammatorydisordersmayinvolveallcomponentsofthepulmonaryvasculature,includingcapillaries.Theprincipalhistopathologicfeaturesofpulmonarycapillaritisincludecapillarywallnecrosiswithinfiltrationbyneutrophils,interstitialerythrocytes,and/orhemosiderin,andinteralveolarseptalcapillaryocclusionbyfibrinthrombi.Immunecomplexdepositionisvariablypresent.Patientsoftenpresentclinicallywithdiffusealveolarhemorrhage,whichischaracterizedbydyspneaandhemoptysis;diffuse,bilateral,alveolarinfiltratesonchestradiograph;andanemia.PulmonarycapillaritishasbeenreportedwithvariablefrequencyandseverityasamanifestationofWegener'sgranulomatosis,microscopicpolyarteritis,systemiclupuserythematosus,Goodpasture'ssyndrome,idiopathicpulmonaryrenalsyndrome,Behcet'ssyndrome,Henoch-Schonleinpurpura,IgAnephropathy,antiphospholipidsyndrome,progressivesystemicsclerosis,anddiphenylhydantoinuse.第3頁/共25頁4Aclinicopathologicstudyof34casesofdiffusepulmonaryhemorrhagewithlungbiopsyconfirmation.

34patientswithbiopsy-confirmeddiffusepulmonaryhemorrhage(DPH).DPHsyndromeswereencountered:antibasementmembraneantibodydisease(fourcases);idiopathicpulmonaryhemorrhage(fourcases);WG(fivecases);probableWG(sixcases);systemicnecrotizingvasculitisotherwiseunclassified(threecases);systemiclupuserythematosus(twocases);rheumatoidarthritis(onecase);seronegativejuvenilerheumatoidarthritis(onecase);IgAnephropathy(onecase);idiopathicglomerulonephritis(twocases--onewithandonewithoutimmunecomplexes);andunclassifiedpulmonary-renalsyndromes(fivecases).Capillaritiswasfoundinlungbiopsysamplesfrom30ofthe34patients(88%)andincludedpatientswitheverytypeofDPHsyndrome.AmJSurgPathol.1990Dec;14(12):1112-25.第4頁/共25頁5Pulmonaryhemorrhage.AfatalmanifestationinIgAnephropathy.

TwopatientswithasymptomaticIgAnephropathy(IgAN)andathirdpatientwithchronicrenalfailureduetoIgANdiedfollowingarecentonsetofdyspnea,hemoptysis,andpulmonaryinfiltrates.Inallcases,thecauseofdeathwasrespiratoryfailureattributedtoeitherbronchopneumoniaorpulmonaryedema.Inallthreepatients,thediagnosesofIgANandidiopathicpulmonaryhemorrhagewereestablishedatpostmortemexamination.Acutealveolarhemorrhagewaspresentintwopatients.Allthreepatientshadheavyalveolarhemosiderin-ladenmacrophages,andcapillaritiswasrecognizedintwoofthem.Theysuggestedanimmunecomplex-mediatedpulmonaryinjurythatwaspossiblyrelatedtothesystemicnatureofIgAN.

ArchPatholLabMed.1994May;118(5):542-6.第5頁/共25頁6IgA腎病與惡性高血壓第6頁/共25頁7惡性高血壓的臨床特征血壓明顯升高,通常舒張壓>130mmHg(16.9kPa);廣泛累及全身小動脈,導(dǎo)致中樞神經(jīng)系統(tǒng)、心、腎等臟器受損,其中以腎臟損害最為顯著;眼底改變包括視網(wǎng)膜出血、棉絮狀滲出及視乳頭水腫等;如不及時治療則預(yù)后不佳,多死于尿毒癥。第7頁/共25頁8惡性高血壓的病因第8頁/共25頁9第9頁/共25頁10

Prognosticfactorsinimmunoglobulin-AnephropathyNinetyeightadultpatientswithdiagnosisofprimaryIgAnephropathy.Outof98patient,64(65.3%)weremen.Meanageofpresentationwas25.7years.Thepredominantrenallesionsincludednephroticsyndromein25(25.5%),rapidlyprogressiverenalfailureandacceleratedmalignanthypertensionin21(21.4%)each,chronicrenalfailurein13(13.3%),hypertensioninnine(9.2%)haematuriainfive(5.1%)andacuterenalfailureinfour(4.1%).Sixty(61%)hadrenalfailureatdiagnosis.Age>25years,glomerularhistologyofHasssubclassVandinterstitialfibrosisweresignificantfactors.Forty(48.2%)(IR)patientsdevelopedESRFduringfollowup.JAssocPhysiciansIndia.2002Nov;50:1354-9.

第10頁/共25頁11

MalignantoracceleratedhypertensioninIgAnephropathy.66adultpatientsdiagnosedashavingIgAnephropathybyrenalbiopsy24(36%)werehypertensivewhenfirstseen.Ofthesehypertensivepatients,10(15%)hadmalignantoracceleratedhypertension.Allpatientsbutoneweremaleandhadnoknowledgeoftheirrenaldiseaseandsoughtmedicaladviceforsymptomsduetohypertension.Fivepatientshadnohistoryofgrosshematuria.Histologicalvascularfindingsshowed,inthreeproliferativeendarteritisandfibrinoidnecrosis,infivearteriolosclerosisandintwovascularhypertrophy.Inspiteofgoodbloodpressurecontrol,sixpatientsreachedterminaluremiawithinamaximumof14months.Patientswiththisassociationreachendstagerenalfailureinashortperiodoftime.

ClinNephrol.1987Jan;27(1):1-7.第11頁/共25頁12“Malignant”IgAnephropathy(1)MostpatientswithmesangialIgAnephropathywhorunaprogressivecourseusuallydosooveraperiodof10to20years.Thispaperdescribesthecourseofthreeyoungmenwithsimilarpresentingfeaturesandbiopsyfindingswhoprogressedtoend-stagerenalfailureinlessthan4yearsfrompresentation,eventhoughinitiallyallhadserumcreatininelevelsthatwereinthenormalrange.

AmJKidneyDis.1985Jan;5(1):42-6.第12頁/共25頁13“Malignant”IgAnephropathy(2)Theypresentedwithmacroscopichematuria,whichhaspreviouslybeenregardedasanindicatorofafavorableprognosis,andallthreehadloinpain,constantlyelevatedurinaryerythrocytecounts,andcrescentsinrenalbiopsies.Intwocases,treatmentappearedtobeassociatedwithstabilizationofrenalfunction,butdeteriorationtoend-stagerenalfailureoccurredrapidlyaftertreatmentwasceased.AmJKidneyDis.1985Jan;5(1):42-6.

第13頁/共25頁14IdiopathicIgAnephropathypresentingasmalignanthypertension.

ThreecasesarereportedofidiopathicIgAnephropathy(Berger'sdisease)presentingasmalignanthypertension,withnodatasuggestingtheunderlyingglomerulopathy,whichwasuncoveredonlyafterrenalbiopsywasperformed.Commentsaremadeonthevalidityofthepathologicaldiagnosis,thepossiblepathogeneticsequenceoftheassociation,andontheeventualrisksandbenefitsderivedfromperformingrenalbiopsyinsuchpatients.

AmJNephrol.1986;6(6):482-6.第14頁/共25頁15惡性高血壓與肺出血第15頁/共25頁16張曉亮查房復(fù)習(xí)男,35歲,C800489入院日期:2003-8-1主訴:雙小腿水腫1年,咯血5月,憋氣3月,加重10余天。第16頁/共25頁17現(xiàn)病史

1年前無明顯誘因出現(xiàn)雙小腿可凹性水腫。間斷頭痛,未測血壓。5月前咳少量痰,帶血絲,逐漸加重有小血塊。并出現(xiàn)憋氣,夜尿增多,夜間尿3-4次,尿量無減少,尿中泡沫增多,雙下肢腫較前明顯加重。03-6月初憋氣加重,夜間不能平臥,雙小腿水腫明顯,晨起后自覺眼瞼浮腫,并出現(xiàn)皮膚、鞏膜較前變黃。第17頁/共25頁18第一次住院情況查體:血壓240/130mmHg,鞏膜黃染,雙下肢可凹性水腫(++)尿常規(guī)PRO5g/L,BLD250/UL;尿蛋白4.96g/d,GFR22.7ml/min,免疫指標(-)。6-10血氣:I型呼衰。6-16腎穿“惡性高血壓腎損害”;胸片、胸部CT:雙肺多發(fā)滲出實變性病變,右側(cè)包裹性胸腔積液;肺V/Q顯像:不支持肺栓塞。心臟彩超:左室肥厚,左房增大,射血分數(shù)57%,輕度肺動脈高壓。入院后Scr增高,1.9~4.5mg/dl,6-15開始甲強0.5g/d*3天沖擊,后改為強的松60mg/日。呼吸科會診考慮咯血為高血壓所致。予降壓藥治療后,血壓控制至140/90mmHg,憋氣等癥狀緩解,強的松減至15mg/天,Cr3.3mg/dl后6-30出院。出院后半月內(nèi)逐漸停用強的松。

第18頁/共25頁19第二次住院情況7月18日再次出現(xiàn)頭痛、憋氣、痰中帶血,浮腫加重,夜間不能平臥。急診查T38.2℃,BP185/87mmHg,SCr5.8mg/dl,胸片:雙肺大片高密度影,肺水腫可能;血氣:PO245.8mmHg,SO283.6%,予CPAP輔助呼吸及抗感染治療,持續(xù)硝普鈉、壓寧定等控制血壓。肺活檢示肺左下葉基底段慢性炎,肺泡腔內(nèi)有較多吞噬含鐵黃素的吞噬細胞。臥位PRA9.4mug/ml,ATⅡ409.6uug/ml,Ald21.7mug/dl24小時尿CA:NE16.43ug/d;E3.43ug/d;DA48.77ug/d24小時尿UFC57.8ug/d第19頁/共25頁20診斷:

惡性高血壓急性腎功能衰竭急性左心功能衰竭高血壓視網(wǎng)膜病變Ⅳ期

肺內(nèi)病變性質(zhì)未明

Ⅰ型呼吸衰竭肺水腫肺泡出血合并感染可能性大肺結(jié)核不除外

2型糖尿病結(jié)節(jié)性甲狀腺腫

第20頁/共25頁21

Malignanthypertensionwithararecomplicationofpulmonaryalveolarhemorrhage.A34-year-oldJapanesemalewithseverehypertension,rapidlyprogressiverenalfailure,blurredvision,dyspneaandhemoptysis.Clinicaldiagnosisofmalignanthypertensionwasgivenandantihypertensivetherapyandhemodialysiswereimmediatelystarted.Renalfunctionwasgraduallyrecoveredandpulmonaryhemorrhagecompletelydisappearedbytreatmentwithantihypertensiveagents.Typicalpathologicalchangesofmalignanthypertension,i.e.fibrinoidnecrosisoftheafferentarteriolesandproliferativeendoarteritisattheinterlobulararterieswereobserved.Theauthorsspeculatethatalveolarhemorrhagemayberelatedtovascularinjuriesatthealveolarcapillarylevelcausedbymalignanthypertension.AmJNephrol.2000Jan-Feb;20(1):64-7.

第21頁/共25頁22

Themechanismoflunghemorrhageinmalignanthypertension(1)Therearefewreportsoflunghemorrhageinmalignanthypertension.Thepathophysiologyofmalignanthypertensioninvolvesvascularorendothilialinjuriescausedbyseverehypertension.Notonlythemechanicalstressofthehighbloodpressurebutalsoother

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論